|Penn’s Neuroscience & Society Lecture Series—Cognitive Enhancing Drugs: Neuroscience and Society
October 6, 2009,
Volume 56, No. 06
Barbara Sahakian, a world-renowned cognitive researcher and Penn Distinguished International Scholar, will present Cognitive Enhancing Drugs: Neuroscience and Society, the first public talk in the Neuroscience & Society Lecture Series on Thursday, October 8, 4-5:30 p.m. in College Hall, Room 200.
Dr. Sahakian, a professor at the University of Cambridge, is a leading expert on the effects of cognitive enhancing drugs on normal, healthy individuals, young and old. Her research is aimed at understanding the neural basis of cognitive, emotional and behavioral dysfunction in order to develop more effective pharmacological and psychological treatments. Recently, results from studies of ecstasy use and cognitive enhancement using methylphenidate, modafinil and atomoxetine have led to her interest in pharmacogenomics and neuroethics.
RSVPs can be sent to email@example.com.
For subsequent lectures in the series, see http://neuroethics.upenn.edu/.
Related: Center for Neuroscience & Society: Panel of Advisors; CNDR 9th Annual
Marian S. Ware Research Retreat